Express Scripts on deal for AbbVie's Viekira: more to come beyond hepatitis C

Express Scripts set a precedent for new, high-priced drugs in the US when the pharmacy benefit manager (PBM) negotiated a deal with AbbVie that gives the pharma company's recently approved four-pill regimen Viekira Pak exclusive reimbursement for patients with genotype 1 hepatitis C.

Express Scripts set a precedent for new, high-priced drugs in the US when the pharmacy benefit manager (PBM) negotiated a deal with AbbVie that gives the pharma company's recently approved four-pill regimen Viekira Pak exclusive reimbursement for patients with genotype 1 hepatitis C.

Unless genotype 1 patients fail or can't tolerate Viekira, the agreement excludes coverage for other new hepatitis C virus (HCV)...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category